03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Lipigard 40mg* : | |
Type | Medicine Non Marketed |
Originator | Lipitor 40mg |
Agent | Pharmanet Drugstore |
Distributor | Pharmanet Drugstore |
Laboratory | Julphar |
Responsible Party | Julphar |
Origin | UAE |
Manufacturer | Egis Pharmaceuticals PLC |
Manufacturing Type | G |
Origin | Hungary |
ATC | C10AA05 |
Lipigard 40mg* :
Lipigard 40mg* :
Lipigard 40mg* :
Lipigard 40mg* :
Lipigard 40mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain lower | Uncommon |
Abdominal pain upper | Uncommon |
Allergic reaction | Common |
Alopecia | Uncommon |
Amnesia | Uncommon |
Anaphylaxis | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Anorexia | Uncommon |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Uncommon |
Back pain | Common |
Blood creatine phosphokinase increased | Common |
Bullous disorder | Rare |
Cephalea | Common |
Chest pain | Uncommon |
Cholestasis | Rare |
Constipation | Common |
Diarrhoea (Diarrhea) | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Common |
Epistaxis (Nasal bleeding) | Common |
Eructation (belching) | Uncommon |
Erythema multiforme | Rare |
Fatigue | Uncommon |
Flatulence | Common |
Gynecomastia (Gynaecomastia) | Very rare |
Hearing loss | Very rare |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Very rare |
Hepatitis | Uncommon |
Hyperglycaemia | Common |
Hypoesthesia | Uncommon |
Hypoglycaemia | Uncommon |
Immune-mediated necrotising myopathy | Not known |
Insomnia | Uncommon |
Joint swelling | Common |
Leukocyturia | Uncommon |
Liver function test abnormal | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
Malaise | Uncommon |
Muscle fatigue | Uncommon |
Muscle spasms | Common |
Myalgia | Common |
Myopathy | Rare |
Myositis | Rare |
Nasopharyngitis | Common |
Nausea | Common |
Neck pain | Uncommon |
Neuropathy peripheral | Rare |
Nightmares | Uncommon |
Oedema peripheral | Uncommon |
Pain in extremity (Pain in limb) | Common |
Pancreatitis | Uncommon |
Paraesthesia (paresthesia) | Uncommon |
Pharyngolaryngeal pain | Common |
Pruritus | Uncommon |
Pyrexia | Uncommon |
Rhabdomyolysis | Rare |
Skin Eruption | Uncommon |
Stevens-Johnson syndrome | Rare |
Tendon rupture | Rare |
Tendonopathy | Rare |
Thrombocytopenia (Thrombopenia) | Rare |
Tinnitus | Uncommon |
Transaminases increased | Not known |
Urticaria | Uncommon |
Vertigo | Uncommon |
Vision blurred | Uncommon |
Visual disturbance | Rare |
Vomiting | Uncommon |
Weight increased (weight gain) | Uncommon |
Lipigard 40mg* :
Lipigard 40mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Lipigard 40mg* MoH 7017 :
Form | Tablet, Film-Coated |
Package Size | Box of 30 |
Strength | 40mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 97465/12 |
Submission date | 01/01/2012 |
Registration Year | 2013 |
Archived Date | 03/04/2023 |
Barcode | 6291100087112 |
Price Comparison
● Country: | UAE | |
● Package Size: | 30's (10's Blister x 3) | |
● Public Price: | 248 AED | ( 5,991,928.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 8,2667 AED | ( 193,288.00 LBP ) |
● Pharmacy Price: | 199.65 AED | ( 4823743.65 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 30 | |
● Public Price: | 166.75 QAR | ( 4,095,046.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 5,5583 QAR | ( 122,790.00 LBP ) |
● Pharmacy Price: | 136.89 QAR | ( 3361744.62 LBP ) |
● Pricing Date: | 20/07/2017 | |
● Type: | Medicine Non Marketed |
● Country: | Abu Dhabi | |
● Package Size: | 30 | |
● Public Price: | 121.5 AED | ( 2,935,561.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 4,05 AED | ( 96,644.00 LBP ) |
● Pharmacy Price: | 97.92 AED | ( 2365845.12 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 30 | |
● Public Price: | 107.05 SAR | ( 2,530,662.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 3,5683 SAR | ( 70,920.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | Boîte de 30 | |
● Public Price: | 12.11 KWD | ( 3,555,265.91 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,4037 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 10.23 KWD | ( 3003333.63 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 30 | |
● Public Price: | 16.73 OMR | ( 3,860,179.82 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,5577 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File